Literature DB >> 19260858

TNFalpha gene silencing reduced lipopolysaccharide-promoted proliferation of endometriotic stromal cells.

Ayako Miyamoto1, Fuminori Taniguchi, Yukiko Tagashira, Ayako Watanabe, Tasuku Harada, Naoki Terakawa.   

Abstract

PROBLEM: We previously reported that lipopolysaccharide (LPS)-promoted endometriotic stromal cell (ESC) proliferation by inducing TNFalpha production. The aim of this study was to investigate the efficacy of TNFalpha gene silencing on LPS-treated ESCs. METHOD OF STUDY: Endometriotic stromal cells (ESCs) and endometrial stromal cells (ESCs) (EMSCs) were obtained from ovarian chocolate cysts and uterine myoma, respectively. Using PCR array, LPS-induced gene expression profiling after transfection of TNFalpha siRNA into ESCs was performed. Down-regulated genes by TNFalpha silencing were examined using real-time RT-PCR. Effect of TNFalpha silencing was examined using ELISA and BrdU incorporation, respectively.
RESULTS: In PCR array, TNFalpha silencing in ESCs repressed LPS-induced expression of cIAP2 and IL-8, NFkappaB pathway responsive genes. After adding LPS, the levels of cIAP2 and IL-8 expression in ESCs were higher compared with those in EMSCs. TNFalpha silencing attenuated the LPS-induced ESC proliferation.
CONCLUSION: Tumor necrosis factor alpha may be involved in cell proliferation of endometriotic tissues.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19260858     DOI: 10.1111/j.1600-0897.2009.00691.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  2 in total

1.  Occurrence of chronic endometritis in different types of human adenomyosis.

Authors:  Khaleque N Khan; Akira Fujishita; Kanae Ogawa; Akemi Koshiba; Taisuke Mori; Kyoko Itoh; Masahiro Nakashima; Jo Kitawaki
Journal:  Reprod Med Biol       Date:  2021-10-15

Review 2.  An Update on the Multifaceted Role of NF-kappaB in Endometriosis.

Authors:  Yuanmeng Liu; Jianzhang Wang; Xinmei Zhang
Journal:  Int J Biol Sci       Date:  2022-07-04       Impact factor: 10.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.